简介：
Overview
This protocol describes a mouse model of incomplete surgical resection of soft tissue sarcoma, allowing for the testing of (neo)adjuvant therapies. It mimics the clinical setting of residual disease after tumor debulking surgery.
Key Study Components
Area of Science
- Oncology
- Preclinical Research
- Surgical Techniques
Background
- Soft tissue sarcoma often relapses locally after surgery.
- The model standardizes the amount of wound and residual tumor.
- It is crucial for identifying new cancer treatments.
- Demonstrates the inversion technique for tumor exposure.
Purpose of Study
- To test new cancer therapies in a controlled postoperative setting.
- To evaluate the effects of therapies on residual disease.
- To improve understanding of wound healing in the context of cancer.
Methods Used
- Subcutaneous inoculation of cancer cells in mice.
- Monitoring tumor growth until reaching a specific size.
- Administration of buprenorphine prior to surgery.
- Application of surgical techniques to model incomplete resection.
Main Results
- Standardized model allows for reproducible results.
- Facilitates the testing of (neo)adjuvant therapies.
- Demonstrates the impact of surgical techniques on tumor behavior.
- Provides insights into postoperative healing processes.
Conclusions
- The model is effective for preclinical studies of soft tissue sarcoma.
- It enhances the understanding of local tumor recurrence.
- Supports the development of new therapeutic strategies.
What is the significance of this mouse model?
It allows researchers to test new therapies in a controlled environment that mimics clinical conditions.
How does the model standardize surgical conditions?
By controlling the extent of the surgical resection and the amount of residual tumor.
What type of cancer is primarily studied with this model?
Soft tissue sarcoma.
What is the role of buprenorphine in this protocol?
It is administered to manage pain in mice prior to surgery.
Why is postoperative wound healing important in this study?
It affects the outcomes of cancer therapies and the understanding of tumor recurrence.
What are the expected outcomes of using this model?
To identify effective (neo)adjuvant therapies and understand their impact on tumor behavior.
繁體中文
